In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...

OXcan was founded in 2020 by Dr. Peter Jianrui Liu and Dr. Andreas Halner to advance early cancer detection using liquid biopsy.

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

Venture capital firm Vensana Capital, headquartered in Minneapolis, has closed a $425 million fund to further fuel medtech startups, some of which are in the Twin Cities. Founded in 2019, Vensana ...

Marks & Clerk says there is a lack of clarity over how IP protection safeguards the innovations underpinning the UK medtech ...

It’s incredibly rewarding to build in the medtech space, but some data suggests the average medical device requires $31 ...

Med Tech & Diagnostics Analysts Matson and Saxon, along with Dr. Kevin Cronin, Assistant Professor of Orthopaedic Surgery at the University ...

This latest edition features an interview with retiring longtime Wilson Sonsini IP partner Vern Norviel and articles on MedTech and pharma trends ...

Leadership in Medtech issue features former Edwards Lifesciences CEO Mike Mussallem and FDA CDRH Director Dr. Michelle Tarver ...

"This is going to be a broad approach. ... There's a big list to go after, but we're committed to make a difference," ...

FlowBeams, creator of the BoldJet needle-free injection showcased itsbreakthrough medtech technology at CES 2025.The company’s innovative needle-free injection ...

Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA ...